Abbott Laboratories (ABT) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbott Laboratories.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.934 Good morning and thank you for standing by. 00:00:01.934 -- 00:00:07.281 Welcome to Abbott's first quarter 2026 earnings conference call. 00:00:07.281 -- 00:00:10.907 All participants will be able to listen only until the question and answer portion of 00:00:10.907 -- 00:00:15.994 this call. During the question and answer session, you will be able to ask your question 00:00:15.994 -- 00:00:20.140 by pressing the star 1 1 keys on your touchstone phone. 00:00:20.140 -- 00:00:25.267 This call is being recorded by Abbott. With the exception of any participants questions 00:00:25.267 -- 00:00:29.905 asked during the question and answer session, the entire call including the question 00:00:29.905 -- 00:00:33.709 and answer session, is material copyrighted by Abbott. 00:00:33.709 -- 00:00:38.955 It cannot be recorded or rebroadcast without Abbott's Express written permission. 00:00:38.955 -- 00:00:44.919 I would now like to introduce Mr. Mike Camilla, Vice President, Investor Relations. 00:00:46.043 -- 00:00:48.465 Good morning, and thank you for joining us. 00:00:48.465 -- 00:00:54.051 With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreau, 00:00:54.051 -- 00:00:58.435 Executive Vice President, Finance and Chief Financial Officer. 00:00:58.435 -- 00:01:01.179 Robert and Phil will provide opening remarks. 00:01:01.179 -- 00:01:04.665 Following their comments, we'll take your questions. 00:01:04.665 -- 00:01:09.072 Before we get started, some statements made today may be forward looking for purposes 00:01:09.072 -- 00:01:13.877 of the Private Securities Litigation Reform Act of 1995, 00:01:13.880 -- 00:01:18.184 including the expected financial results for 2026. 00:01:18.601 -- 00:01:23.728 Abbott cautions t...